The protective function of adiponectin and DsbA-L in metabolism implies the essential use of adiponectin, DsbA-L, etc. as therapeutic targets when treating metabolism-related diseases such as obesity and diabetes. This evidence concerns the gene ADIPOQ and diabetes mellitus.